Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression

This publication has 19 references indexed in Scilit:

• TNP-470 (AGM-1470): Mechanisms of action and early clinical development
  European Journal Of Cancer, 1996
• Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
  Published by Elsevier ,1996
• Stimulation of Human B-Lymphocyte Proliferation by AGM-1470, a Potent Inhibitor of Angiogenesis
  JNCI Journal of the National Cancer Institute, 1995
• Chemical Modification of Fumagillin. III. Modification of the Spiro-epoxide.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
• Suppression of Cyclin D1 mRNA Expression by the Angiogenesis Inhibitor TNP-470 (AGM-1470) in Vascular Endothelial Cells
  Biochemical and Biophysical Research Communications, 1994
• Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470
  Inflammation Research, 1993
• Chemical Modification of Fumagillin. I. 6-O-Acyl, 6-O-Sulfonyl, 6-O-Alkyl, and 6-O-(N-Substituted-carbamoyl)fumagillols.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
• Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
  Nature, 1990
• On the Mode of Action of the Immunosuppressive Sesquiterpene Ovalicin
  European Journal of Biochemistry, 1981
• On the Mechanism of Action of the Cytostatic Drug Anguidine and of the Immunosuppressive Agent Ovalicin, two Sesquiterpenes from Fungi¹
  Planta Medica, 1978